亿腾医药过港交所聆讯，2020年收入达17.68亿元

智通财经2021-06-25

据港交所6月25日披露，亿腾医药(Edding Group Company Limited)通过港交所主板上市聆讯，摩根士丹利及瑞信为联席保荐人。亿腾医药为专注于抗感染、心血管疾病及呼吸系统的中国领先医药公司。公司的三种核心商业化产品包括两种抗感染药物(希刻劳及稳可信)与一种呼吸系统药物(FPN)。公司日后的经营业绩，一部分要取决于其集中经营该等产品，亦包括其他产品及在研新药(例如...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

孤魂野鬼婷婷
2021-06-25
孤魂野鬼婷婷
[微笑]
孤魂野鬼婷婷
2021-06-25
孤魂野鬼婷婷
[微笑]
虎妞8888888
2021-06-25
虎妞8888888
[开心]
山风_8300
2021-06-25
山风_8300
👍
梓笋
2021-06-25
梓笋
呼呼呼呼

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2146689027?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/f874ded00c644297784368a7af94c8ae","is_english":false,"pubTime":"2021-06-25 14:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2146689027","market":"hk","top_or_hot":-1,"title":"亿腾医药过港交所聆讯，2020年收入达17.68亿元","media":"智通财经","content":"<div>\n<p>据港交所6月25日披露，亿腾医药(Edding Group Company Limited)通过港交所主板上市聆讯，摩根士丹利及瑞信为联席保荐人。\n\n亿腾医药为专注于抗感染、心血管疾病及呼吸系统的中国领先医药公司。公司的三种核心商业化产品包括两种抗感染药物(希刻劳及稳可信)与一种呼吸系统药物(FPN)。公司日后的经营业绩，一部分要取决于其集中经营该等产品，亦包括其他产品及在研新药(例如...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/501098.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title> 亿腾医药过港交所聆讯，2020年收入达17.68亿元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n 亿腾医药过港交所聆讯，2020年收入达17.68亿元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-25 14:21 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/501098.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>据港交所6月25日披露，亿腾医药(Edding Group Company Limited)通过港交所主板上市聆讯，摩根士丹利及瑞信为联席保荐人。\n\n亿腾医药为专注于抗感染、心血管疾病及呼吸系统的中国领先医药公司。公司的三种核心商业化产品包括两种抗感染药物(希刻劳及稳可信)与一种呼吸系统药物(FPN)。公司日后的经营业绩，一部分要取决于其集中经营该等产品，亦包括其他产品及在研新药(例如...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/501098.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"159938","symbol_name":"医药","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/501098.html","article_id":"2146689027","we_media_id":null,"thumbnails":["https://static.tigerbbs.com/f874ded00c644297784368a7af94c8ae"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2146689027","pubTimestamp":1624602064,"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"据港交所6月25日披露，亿腾医药(Edding Group Company Limited)通过港交所主板上市聆讯，摩根士丹利及瑞信为联席保荐人。\n\n亿腾医药为专注于抗感染、心血管疾病及呼吸系统的中国","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159938":"医药","09939":"开拓药业-B"},"translate_title":"Yiteng Medicine has been heard by the Hong Kong Stock Exchange, and its revenue in 2020 reached 1.768 billion yuan","themeId":null,"isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/2c5e6845013e4bf15a3a1977c2d693d7","symbols_score_info":{"159938":0.9,"09939":0.9},"content_text":"据港交所6月25日披露，亿腾医药(Edding Group Company Limited)通过港交所主板上市聆讯，摩根士丹利及瑞信为联席保荐人。\n\n亿腾医药为专注于抗感染、心血管疾病及呼吸系统的中国领先医药公司。公司的三种核心商业化产品包括两种抗感染药物(希刻劳及稳可信)与一种呼吸系统药物(FPN)。公司日后的经营业绩，一部分要取决于其集中经营该等产品，亦包括其他产品及在研新药(例如Vascepa及Mulpleta)。\n招股书显示，亿腾医药广泛的销售及营销网络由约850名销售代表组成，截至2020年12月31日，覆盖中国31个省份逾22,000间医院。\n2017年、2018年、2019年及2020年，公司收入分别为17.869亿元(人民币，下同)、14.78亿元、18.75亿元及17.68亿元;同期利润分别为亏损3853.8万元、亏损2.15亿元、纯利1.73亿元及8693.9万元，公司收入主要来自药品销售。\n亿腾医药大致倚赖于且收入主要来自核心商业化产品。2017-2020年度，稳可信产生的收入分别为8.699亿元、7.952亿元、7.266亿元及10.189亿元;希刻劳产生的收入分别为3.898亿元、2.451亿元、2.805亿元及4.774亿元。公司于2020年5月向GSK收购核心呼吸系统产品丙酸氟替卡松雾化吸入用混悬液(FPN)，于2020年，FPN产生的收入为9180万元。\n\n公司计划将募集所得用于1)备选产品的持续研发;2)进一步丰富产品组合;3)生产及研发设施的扩展及升级;4)偿还用于收购希刻劳与稳可信的瑞士信贷银行股份有限公司新加坡分行、浦银国际(香港)有限公司及Ace City Venture Limited的部分银团贷款;5)营运资金及一般企业用途。","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":122480101,"gmtCreate":1624630033303,"gmtModify":1633950309848,"author":{"id":"4087552599844040","authorId":"4087552599844040","name":"孤魂野鬼婷婷","avatar":"https://static.tigerbbs.com/50acda89ce84ad538794fd7ea2ec2fc3","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"[微笑]&nbsp;","listText":"[微笑]&nbsp;","text":"[微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/122480101","repostId":2146689027,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":122415856,"gmtCreate":1624629953875,"gmtModify":1633950312258,"author":{"id":"4087552599844040","authorId":"4087552599844040","name":"孤魂野鬼婷婷","avatar":"https://static.tigerbbs.com/50acda89ce84ad538794fd7ea2ec2fc3","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"[微笑]&nbsp;","listText":"[微笑]&nbsp;","text":"[微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/122415856","repostId":2146689027,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":122234708,"gmtCreate":1624622182104,"gmtModify":1633950440539,"author":{"id":"4087356343176020","authorId":"4087356343176020","name":"虎妞8888888","avatar":"https://static.tigerbbs.com/906254e738bd499fe64bbb3ce933b714","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"[开心]&nbsp;","listText":"[开心]&nbsp;","text":"[开心]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/122234708","repostId":2146689027,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":122126907,"gmtCreate":1624605709709,"gmtModify":1633950615134,"author":{"id":"3572785300913507","authorId":"3572785300913507","name":"山风_8300","avatar":"https://static.tigerbbs.com/297d7c59c9be350172849ef10e98943c","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/122126907","repostId":2146689027,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":122186852,"gmtCreate":1624604194376,"gmtModify":1633950627919,"author":{"id":"3573083490665949","authorId":"3573083490665949","name":"梓笋","avatar":"https://static.tigerbbs.com/8a294795cbcf0a404e687023dcd20aeb","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"呼呼呼呼","listText":"呼呼呼呼","text":"呼呼呼呼","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/122186852","repostId":2146689027,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":7,"commentSize":5,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2146689027"}